Group One Trading’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-65,000
| Closed | -$14.4M | – | 7731 |
|
|
2025
Q4 | $14.4M | Buy |
65,000
+31,800
| +96% | +$5.14M | 0.03% | 726 |
|
|
2025
Q3 | $3.18M | Buy |
33,200
+28,700
| +638% | +$1.83M | 0.01% | 1892 |
|
|
2025
Q2 | $219K | Buy |
+4,500
| New | +$108K | ﹤0.01% | 4239 |
|
|
2024
Q3 | – | Sell |
-8,700
| Closed | -$104K | – | 6699 |
|
|
2024
Q2 | $104K | Buy |
8,700
+8,215
| +1,694% | +$112K | ﹤0.01% | 3932 |
|
|
2024
Q1 | $8.92K | Sell |
485
-665
| -58% | -$9.55K | ﹤0.01% | 5929 |
|
|
2023
Q4 | $18.3K | Sell |
1,150
-380
| -25% | -$6.1K | ﹤0.01% | 5817 |
|
|
2023
Q3 | $28.8K | Sell |
1,530
-370
| -19% | -$7.26K | ﹤0.01% | 5582 |
|
|
2023
Q2 | $42.9K | Buy |
1,900
+1,640
| +631% | +$38.5K | ﹤0.01% | 5397 |
|
|
2023
Q1 | $6.6K | Buy |
+260
| New | +$7.38K | ﹤0.01% | 6162 |
|
|
2022
Q2 | – | Sell |
-1,195
| Closed | -$20K | – | 7864 |
|
|
2022
Q1 | $20K | Sell |
1,195
-575
| -32% | -$9.75K | ﹤0.01% | 6738 |
|
|
2021
Q4 | $45K | Buy |
1,770
+1,395
| +372% | +$43.4K | ﹤0.01% | 6414 |
|
|
2021
Q3 | $17K | Sell |
375
-2,235
| -86% | -$84.9K | ﹤0.01% | 7257 |
|
|
2021
Q2 | $105K | Buy |
2,610
+2,560
| +5,120% | +$108K | ﹤0.01% | 5896 |
|
|
2021
Q1 | $3K | Buy |
50
+30
| +150% | +$1.48K | ﹤0.01% | 7329 |
|
|
2020
Q4 | $1K | Sell |
20
-35
| -64% | -$1.74K | ﹤0.01% | 6319 |
|
|
2020
Q3 | $3K | Sell |
55
-435
| -89% | -$30.7K | ﹤0.01% | 5733 |
|
|
2020
Q2 | $36K | Buy |
490
+35
| +8% | +$2.27K | ﹤0.01% | 4548 |
|
|
2020
Q1 | $23K | Buy |
+455
| New | +$27.3K | ﹤0.01% | 4153 |
|
|
2019
Q4 | – | Sell |
-410
| Closed | -$16K | – | 5148 |
|
|
2019
Q3 | $16K | Buy |
+410
| New | +$13.8K | ﹤0.01% | 4428 |
|
|
2018
Q2 | – | Sell |
-525
| Closed | -$42K | – | 5115 |
|
|
2018
Q1 | $42K | Buy |
+525
| New | +$71.7K | ﹤0.01% | 3741 |
|
Group One Trading's CDTX Position: Q4 2025 in Review
Group One Trading sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 21,403 shares — an estimated $3.46M sold.
Group One Trading first reported a position in CDTX in Q1 2018 and held it in 15 quarters. The position peaked at $2.05M in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.
- Group One Trading reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 21,403 Cidara Therapeutics shares in Q4 2025, an estimated $3.46M.
- Group One Trading first reported a position in Cidara Therapeutics in Q1 2018 and held it in 15 quarters.
- Group One Trading's Cidara Therapeutics position peaked at $2.05M in Q3 2025.
- 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.